Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FY 2020 Audited Financial Statement.

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Apr 28, 2021 12:53pm

160 Views

Post# 33083212

RE:FY 2020 Audited Financial Statement.

MD&A page 14:

"As of December 31, 2020, the Company has cash and cash equivalents of $7,880,243 and as a result the Company believes that it will be able to continue as a going concern for at least 12 months from the date of these audited consolidated financial statements."